Mergent, Inc. Announces Changes to the HealthShares(TM) Cancer Index, Composite Index, Dermatology and Wound Care Index, Enablin
September 03 2008 - 4:05PM
PR Newswire (US)
NEW YORK, Sept. 3 /PRNewswire/ -- Mergent, Inc., administrator for
the HealthShares(TM) Indexes, a series of 20 underlying indexes for
the HealthShares(TM) Exchange Traded Funds, today announced the
following changes with effect from the opening of trade on Monday
September 8, 2008: Nippon Kayaku Co., Ltd (Tokyo SE: 4272) will
replace APP Pharmaceuticals (NASDAQ: APPX) in the HealthShares(TM)
Cancer Index, Genmab AS (OMX Nordic Exchange Copenhagen: GEN) will
replace APP Pharmaceuticals (NASDAQ:APPX) in the HealthShares(TM)
Composite Index, Photocure ASA (Oslo, Norway: PHO) will replace APP
Pharmaceuticals (NASDAQ:APPX) in the HealthShares(TM) Dermatology
and Wound Care Index, Affymetrix Inc. (NASDAQ:AFFX) will replace
APP Pharmaceuticals (NASDAQ:APPX) in the HealthShares(TM) Enabling
Technologies, Cytos Biotechnology AG (SWX, Switzerland: CYTN) will
replace APP Pharmaceuticals (NASDAQ:APPX) in the HealthShares(TM)
Infectious Disease Index. APP Pharmaceuticals is being acquired by
Fresnius SE (Frankfurt, Germany: FRE) through a cash tender offer.
(Logo: http://www.newscom.com/cgi-bin/prnh/20080204/CLM073LOGO )
Companies included in the HealthShares(TM) Cancer Index are engaged
in the research, clinical development and/or commercialization of
therapeutic agents for the treatment of a wide variety of cancers.
The HealthShares(TM) Composite Index consists of the 80 largest
companies, by market capitalization, that are engaged in
healthcare, life sciences and/or biotechnology that are part of the
16 underlying HealthShares(TM) Indexes, selecting the top 5
companies in market capitalization from each of the Composite
Eligible Indexes. Companies included in the HealthShares(TM)
Dermatology and Wound Care Index are engaged in the research,
clinical development and/or commercialization of therapeutic agents
for the treatment of a wide variety of skin disorders by topical or
systemic means. Companies included in the HealthShares(TM) Enabling
Technologies Index provide technology products and/or services that
enable and support the discovery, clinical development and
manufacturing activities of pharmaceutical and biotechnology
companies, including but not limited to genomics, proteomics, and
high throughput screening. Companies included in the
HealthShares(TM) Infectious Disease Index are engaged in the
research, clinical development and/or commercialization of
therapeutic agents for the treatment of a wide variety of
infectious diseases related to antibacterial, antifungal and
antiviral indications, by means of small molecules, protein therapy
and vaccines. About Mergent Mergent, Inc. is a leading provider of
business and financial data on global publicly listed companies.
Based in the U.S., the company maintains a strong global presence,
with offices in New York, Charlotte, San Diego, London, Tokyo and
Melbourne. Founded in 1900, Mergent operates the longest
continuously collected database of: descriptive and fundamental
information on domestic and international companies; pricing and
terms and conditions data on fixed income and equity securities;
and corporate action data. In addition, Mergent develops and
licenses equity and fixed income investment products based on its
proprietary investment methodologies. Mergent-licensed products
have approximately $3.5 billion in assets under management and are
offered by major investment management firms. Mergent's index
calculation platform is the chosen technology for some of the
world's largest index companies. Its index calculation and pricing
distribution protocols are used to administer index rules and
distribute real-time pricing data. For more information, please
visit http://www.mergent.com/ and http://www.dividendachievers.com/
. http://www.newscom.com/cgi-bin/prnh/20080204/CLM073LOGO
http://photoarchive.ap.org/ DATASOURCE: Mergent, Inc. CONTACT:
Brian Whelan, Managing Director, Marketing Communications,
+1-704-559-7989, , or Kevin Heckert, Director, Equity Research,
+1-704-559-6986, , both of Mergent, Inc. Web site:
http://www.mergent.com/ http://www.dividendachievers.com/
Copyright
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Sep 2024 to Oct 2024
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Oct 2023 to Oct 2024